Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Interest in Electronic Applications for Patients With Glaucoma (GlaucomaApp)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02659709
Recruitment Status : Completed
First Posted : January 20, 2016
Results First Posted : August 5, 2019
Last Update Posted : August 5, 2019
Sponsor:
Information provided by (Responsible Party):
Jonathon Myers, Wills Eye

Study Type Observational
Study Design Observational Model: Cohort;   Time Perspective: Prospective
Condition Glaucoma
Intervention Device: Interest in medical education through social media
Enrollment 50
Recruitment Details Glaucoma patients and Caregivers were recruited from the Glaucoma Service at Wills Eye Hospital, Philadelphia, PA, USA.
Pre-assignment Details  
Arm/Group Title Glaucoma Patients and Caregivers
Hide Arm/Group Description Glaucoma patients and caregivers will test a glaucoma smartphone application (app) on smart phones or tablets then complete 20 item questionnaire providing demographic information, effectiveness and ease of use with the application designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
Period Title: Overall Study
Started 50
Completed 50
Not Completed 0
Arm/Group Title Glaucoma Patients and Caregivers
Hide Arm/Group Description 50 Glaucoma patients and/or caregivers will test a glaucoma application (app) on smart phones or tablets then complete a 20 item questionnaire providing demographic information, effectiveness and ease of use with the application designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
Overall Number of Baseline Participants 50
Hide Baseline Analysis Population Description
Fifty participants agreed to answer questions in the survey.
Age, Categorical  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 50 participants
<=18 years
1
   2.0%
Between 18 and 65 years
32
  64.0%
>=65 years
17
  34.0%
Sex: Female, Male  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 50 participants
Female
32
  64.0%
Male
18
  36.0%
Race (NIH/OMB)  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 50 participants
American Indian or Alaska Native
0
   0.0%
Asian
2
   4.0%
Native Hawaiian or Other Pacific Islander
0
   0.0%
Black or African American
9
  18.0%
White
33
  66.0%
More than one race
3
   6.0%
Unknown or Not Reported
3
   6.0%
Region of Enrollment  
Measure Type: Number
Unit of measure:  Participants
United States Number Analyzed 50 participants
50
1.Primary Outcome
Title Patients Owning Smartphone/Tablet Technology
Hide Description Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Time Frame 1 hour
Hide Outcome Measure Data
Hide Analysis Population Description
Participants responding Yes to owning a smartphone or tablet.
Arm/Group Title Glaucoma Smartphone Application
Hide Arm/Group Description:

Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications.

From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.

Overall Number of Participants Analyzed 50
Measure Type: Count of Participants
Unit of Measure: Participants
34
  68.0%
2.Primary Outcome
Title Patients Having Access to Social Media Via Smartphone or Tablet in the Home
Hide Description Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Time Frame 1 hour
Hide Outcome Measure Data
Hide Analysis Population Description
Participants responding Yes to anyone in the house owning a smartphone or tablet.
Arm/Group Title Glaucoma Smartphone Application
Hide Arm/Group Description:

Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications.

From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.

Overall Number of Participants Analyzed 50
Measure Type: Count of Participants
Unit of Measure: Participants
39
  78.0%
3.Secondary Outcome
Title Glaucoma Medication Compliance
Hide Description Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.
Time Frame 1 hour
Hide Outcome Measure Data
Hide Analysis Population Description
Participants responding Yes using their glaucoma eye drops as prescribed.
Arm/Group Title Glaucoma Smartphone Application
Hide Arm/Group Description:

Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications.

From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.

Overall Number of Participants Analyzed 50
Measure Type: Count of Participants
Unit of Measure: Participants
25
  50.0%
4.Secondary Outcome
Title Use of Medication Reminder
Hide Description Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.
Time Frame 1 hour
Hide Outcome Measure Data
Hide Analysis Population Description
Participants responding Yes to using their glaucoma eye drops as prescribed without reminders.
Arm/Group Title Glaucoma Smartphone Application
Hide Arm/Group Description:

Glaucoma patients and/or caregivers answered a Questionnaire on availability to Smartphone or Tablet Usage and accessing social media. Questionnaire includes 20 items regarding demographic information, effectiveness of social media and compliance with glaucoma medications.

From this information, Smartphone Application will be designed to educate glaucoma patients about the disease, testing, and treatments and also include reminders for taking medications.

Overall Number of Participants Analyzed 50
Measure Type: Count of Participants
Unit of Measure: Participants
28
  56.0%
Time Frame 1 hour
Adverse Event Reporting Description [Not Specified]
 
Arm/Group Title Glaucoma Smartphone Application
Hide Arm/Group Description

50 Glaucoma patients and caregivers will test a glaucoma smartphone application (app) on smart phones or tablets then complete 20 item questionnaire providing demographic information, effectiveness and ease of use with the application.

Smartphone Application: Smartphone Application designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.

All-Cause Mortality
Glaucoma Smartphone Application
Affected / at Risk (%)
Total   0/50 (0.00%) 
Hide Serious Adverse Events
Glaucoma Smartphone Application
Affected / at Risk (%)
Total   0/50 (0.00%) 
Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
Glaucoma Smartphone Application
Affected / at Risk (%)
Total   0/50 (0.00%) 
Participants were recruited from single urban eye care hospital. Results did not distinguish between glaucoma patients and caregivers. Participation did not include testing of the application.
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Dr. Jonathan S. Myers
Organization: Wills Eye Hospital, Glaucoma Service
Phone: 215-928-3197
EMail: jmyers@willseye.org
Layout table for additonal information
Responsible Party: Jonathon Myers, Wills Eye
ClinicalTrials.gov Identifier: NCT02659709    
Other Study ID Numbers: 14-413E
First Submitted: August 6, 2015
First Posted: January 20, 2016
Results First Submitted: December 15, 2017
Results First Posted: August 5, 2019
Last Update Posted: August 5, 2019